Kiniksa Pharmaceuticals International (KNSA) Earnings Date
The next earnings date for Kiniksa Pharmaceuticals International (KNSA) is around Jan 11, 2027, estimated from its own calendar.
- Next earnings date
- Around Jan 11, 2027
- estimated from its own calendar · quarter ending Dec '26
- Latest stored quarter
- EPS 0.56
- revenue $286.0M · reported Oct 27, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
All 2 scored quarters beat.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Oct 27, 20268-K, before open · 7:30 am ET | 0.37 | 0.56 | +51.0% | $260.7M | $286.0M | +9.7% | +22.2%release day |
| Jul 28, 20268-K, before open · 7:33 am ET | 0.30 | 0.30 | +0.2% | $226.5M | $243.6M | +7.6% | +25.0%release day |
| Apr 28, 20268-K, before open · 7:32 am ET | — | 0.27 | — | — | $214.3M | — | +23.5%release day |
| Jan 12, 20268-K, after close · 5:22 pm ET | — | 0.18 | — | — | $202.1M | — | −6.1%next session |
| Oct 28, 20258-K, before open · 7:39 am ET | — | 0.23 | — | — | $180.9M | — | −2.9%release day |
| Jul 29, 20258-K, before open · 7:30 am ET | — | 0.23 | — | — | $156.8M | — | +12.3%release day |
| Apr 29, 20258-K, before open · 7:40 am ET | — | 0.11 | — | — | $137.8M | — | +20.5%release day |
| Jan 13, 20258-K, before open · 7:34 am ET | — | −0.11 | — | — | $122.5M | — | −8.8%release day |
Estimate-vs-actual scoring began Jul 2026 and is still accruing: 2 of the 8 quarters above carry a scored estimate. We never backfill an estimate we didn't observe.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 3 | 3 | 4 | 4 |
| Avg estimate | 0.25 | 0.35 | 1.48 | 2.03 |
| Low estimate | 0.20 | 0.26 | 1.43 | 1.57 |
| High estimate | 0.33 | 0.44 | 1.52 | 2.63 |
| Year-ago EPS | 0.18 | 0.27 | 0.75 | 1.48E |
| Implied growth | +39.5% | +31.1% | +97.9% | +36.5% |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 4 | 3 | 5 | 5 |
| Avg estimate | $306.6M | $313.8M | $1.0B | $1.3B |
| Low estimate | $305.9M | $309.1M | $1.0B | $1.3B |
| High estimate | $307.2M | $318.5M | $1.1B | $1.4B |
| Year-ago revenue | $202.1M | $214.3M | $677.6M | $1.0BE |
| Implied growth | +51.7% | +46.4% | +54.9% | +26.2% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | 0.25 | 0.35 | 1.48 | 2.03 |
| 7 days ago | 0.25 | — | 1.48 | 2.03 |
| 30 days ago | 0.36 | — | 1.37 | 2.02 |
| 60 days ago | 0.37 | — | 1.39 | 2.05 |
| 90 days ago | 0.39 | — | 1.39 | 2.05 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $0.39 → $0.25 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Kiniksa Pharmaceuticals International report earnings next?
Kiniksa Pharmaceuticals International's next earnings date is around Jan 11, 2027, estimated from its own calendar.
What were Kiniksa Pharmaceuticals International's latest quarterly earnings?
Kiniksa Pharmaceuticals International reported diluted EPS of 0.56 and revenue of $286.0M on Oct 27, 2026.
How did Kiniksa Pharmaceuticals International's stock move after its last earnings report?
Kiniksa Pharmaceuticals International moved +22.2% in the session after its Oct 27, 2026 report.

